MELACINE
MELACINE
Discontinued
DIN Number
02241211
Drug Class
Human
Market Date
Jan 25, 2001
Company
HC
CORIXA CORPORATION
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02241211
AIG Number0338961001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L03AX12 MELANOMA VACCINE
Product Specifications
Dosage FormPowder
,
Kit
Route of AdministrationIntramuscular
AHFS Classification92:92.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
CELL WALL SKELETONActive
Strength: 500 MCG / VIAL
Monograph: CELL WALL SKELETON
MELANOMA LYSATEActive
Strength: 20000000 CELLS / VIAL
Monograph: MELANOMA LYSATE
MONOPHOSPHORYL LIPID AActive
Strength: 50 MCG / VIAL
Monograph: MONOPHOSPHORYL LIPID A